The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

natx.com

About Nature Technology

Nature Technology Corporation is a developer and provider of non-viral vectors, technologies, and services for advancing gene and cell therapy and immunotherapy. It is based in Lincoln, Nebraska.

Nature Technology Headquarter Location

4701 Innovation Drive Suite 103

Lincoln, Nebraska, 68521,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Nature Technology News

Plasmid DNA Manufacturing Market Size to Worth Around US$ 2.1 Bn by 2030

Oct 11, 2021

Regional Snapshots North America is the leading plasmid DNA manufacturing market. The growing investments in the development of new biopharmaceutical medicines are resulting in rise in the number of contract manufacturers in the region. Moreover, US hold the maximum intellectual property copyrights for majority of the newly developed medicines. The higher adoption rate of advanced healthcare services coupled with growing preferences for gene and cell therapies among the population is a major factor that propelled the demand for the plasmid DNA manufacturing market in North America. The continuous research and development activities towards the development of new biopharma medicines are expected to foster market growth in the forthcoming years. Along with the growth of the contract manufacturers, North America is also hub for the numerous contract research organizations that facilitates development of new medicines. Asia Pacific is expected to witness highest growth rate throughout the forecast period owing to the growing manufacturing of plasmid DNA in the region. The world’s largest contract manufacturing company, GenScript started its operation in China by setting up a plasmid and virus facility in December 2019. This is a major development in the Asia Pacific plasmid DNA manufacturing market. Furthermore, the presence of Biocon in India and Samsung Biologics in South Korea are witnessing spike in their sales in the past few years. These factors are expected to boost the plasmid DNA manufacturing market in the region. Report Highlights By product type, the viral vector segment led the global plasmid DNA manufacturing market with remarkable revenue share in 2020. The demand for the viral vector in the production of vaccines, cell therapies, and gene therapies is already very huge across the globe. The COVID-19 pandemic further boosted its increasing demand for the vaccine production. By application, the gene therapy segment led the global plasmid DNA manufacturing market with remarkable revenue share in 2020.This is because of the growing confidence of the people regarding the effectiveness, reliability, and safety of the gene therapies in the treatment of various chronic and genetic diseases. By disease, the cancer segment is expected to be the fastest-growing segment throughout the forecast period, owing to the increasing uses of the plasmid DNA in the development of various treatment therapies for the cancer Market Dynamics Drivers The growing usage of plasmid DNA for the development of vaccines is fueling the demand. The plasmid DNA is extensively used for developing vaccines for diseases such as influenza, HIV, malaria, pathogens, and Ebola. The DNA vaccines are highly effective and hence, it is increasingly used, thereby fostering the consumption of plasmid DNA. Restraints Various risks related to gene therapies like mutagenesis may hamper the market growth. Further, stringent government regulations and high costs involved may restrict the adoption of gene therapies. These factors have an adverse effect on the market. Opportunities Growing investments and innovations in the biopharmaceutical industry to develop innovative manufacturing technologies to increase the commercial production output of the plasmid DNA may have a big impact on the market during the forecast period. Challenges Lack of adequate infrastructure and financial limitations poses a challenge to carry on the smooth functioning of the research and developmental activities in the field of plasmid DNA manufacturing. Key Players The major players in the market are VGXI, Inc., Vigene Biosciences, Luminous Biosciences, Akron Biotech, Aldevron, Cobra Biologics & Pharmaceutical Services, Plasmidfactory GmbH, Nature Technology Corporation, Delphi Genetics, JAFRAL Ltd. Segments Covered in the Report By Product - Viral Vectors, Plasmid DNA, Non-Viral, Electroporation, Lipid/Polymer, Nanoparticles and Others By Application - Gene Therapy, DNA Vaccines, Immunotherapy, and Others By Disease - Infectious Disease, Genetic Disorder, and Cancer By Geography - North America (U.S., Canada); Europe (U.K., Germany, France); Asia Pacific (China, India, Japan, South Korea; Rest of the World Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1299 You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333 About Us Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally. For Latest Update Follow Us:

Nature Technology Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Nature Technology Rank

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.